Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Burdock Root

Boxers Holyfield, Retta To Participate In HIV/AIDS Charity Fight In Ethiopia
Boxer Evander Holyfield will fight Sammy Retta on July 26 in Ethiopia in an effort to raise money for HIV/AIDS organizations, Reuters India reports. Event organizers hope to raise between $5 million and $10 million from the fight. "I continue to strive to be the very best, but what got me to come here is" HIV/AIDS, Holyfield said, adding, "If we don"t find a cure to this, we"ll be extinct." According to Everton Boland -- CEO of Golden Globe, which is promoting the fight -- a significant portion of money raised will go directly to organizations addressing HIV/AIDS. Organizers said that a group established by African first ladies is the only recipient selected to date but they are considering others (Malone, Reuters India, 5/20).
generic viagra online
Battles Over Insurance Reform Afflict House Dems
"House liberals are offended that Speaker Nancy Pelosi (D-Calif.) mocked their threats to oppose a Democratic healthcare bill, saying leaders are underestimating their frustration over a deal cut with centrist Blue Dogs," The Hill reports. "Rep. Lynn Woolsey (D-Calif.), co-chairwoman of the Congressional Progressive Caucus, on Monday expressed outrage at the comments and said her group is being "laughed at." Woolsey is the author of a letter signed by 60 fellow House liberals vowing to vote against a deal cut with the Blue Dogs ... Woolsey said the signers of the letter plan to "remind leadership" of the group"s support for a "robust public option." "Robust" to liberals generally means similar to Medicare. Liberals are irritated leaders granted Blue Dogs" concessions that prevent the public option from using Medicare rates for reimbursement. They believe that will make care too expensive for many people" (Soraghan and Allen, 8/3).
News of the day
Nepean Dyspepsia Index Applies To Functional Dyspepsia In China
FD, a common non-organic disease in the world, greatly affects a patient"s quality of life. However, treatment of FD is still controversial and no single therapy is uniformly effective, due, in part, to absence of a reliable evaluation instrument. The Nepean Dyspepsia Index (NDI), measuring both symptom scores and impairment of the dyspepsia-specific health-related quality of life in FD patients, has been designed to diagnose FD and has been translated into several languages. Moreover, its utility has been proved to be validated by researches in western countries. However, DI has not been translated and validated in China.
Oncology

Funding For Research On The H1N1 Flu Virus Announced By Government Of Canada

The Honourable Leona Aglukkaq, Minister of Health, is pleased to announce another measure to address the H1N1 flu virus. The Government of Canada will fund a national influenza research network focused on pandemic vaccine evaluation. The network will strengthen Canada"s capacity to evaluate the safety and effectiveness of a pandemic influenza vaccine and vaccination programs. The network was created through a partnership between the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada (PHAC). It will be led by Dr. Scott Halperin, Director of the Canadian Centre for Vaccinology in Halifax. It will link over 80 scientists from 30 research and public health institutions across Canada. "The development and delivery of an effective influenza vaccine are critical to addressing the H1N1 flu virus, said Minister Aglukkaq. This research network will help ensure that Canadians have a safe vaccine that can be provided quickly." The network will provide a pan-Canadian coordinating mechanism for conducting applied public health research that will help governments and the public health community prepare for and respond to an influenza pandemic. Network scientists will: * test methodologies for the performance of rapid clinical trials * assess the safety and immunogenicity of a novel pandemic influenza vaccine * provide population-based estimates of vaccine safety and effectiveness * measure vaccine coverage * facilitate the rapid implementation of pandemic influenza vaccine programs "Canada is fortunate to have a strong community of internationally-recognized infectious disease researchers," says Dr. Alain Beaudet, President of CIHR. "Through the leadership of Dr. Bhagirath Singh, Scientific Director of CIHR"s Institute of Infection and Immunity, and in close collaboration with PHAC, CIHR has moved swiftly to mobilize this group of highly dedicated researchers to respond to the current flu outbreak." "This flu network speaks to the very core of the Public Health Agency of Canada"s mandate to protect Canadians from the threat of emerging diseases," says Dr. David Butler Jones, Canada"s Chief Public Health Officer, "Supporting this initiative in partnership with CIHR gives us all an ideal mechanism to learn more about influenza in Canada and how to improve our responses to current and future outbreaks." Minister Aglukkaq also announced funding to support the work of two national pandemic outbreak research teams: Dr. Guy Boivin at Universitç© Laval and his team will work with a national team to track the evolution of the H1N1 flu virus, evaluate its susceptibility to antiviral drugs, and identify new potential therapeutic compounds to combat viral resistance. Dr. Babak Pourbohloul at the University of British Columbia and his team will work with the Canadian Consortium for Pandemic Preparedness Modelling to create mathematical models to rapidly analyze the transmission and spread of the influenza virus and evaluate the effectiveness of various public health intervention strategies. The work of these teams will help public health officials across Canada in their efforts to plan, design and evaluate interventions to address the virus and protect the health of Canadians. These teams are funded through CIHR"s pandemic preparedness strategic research initiative, and they were pre-selected through a competitive, peer-review process conducted by CIHR. In the 2006 Federal Budget, the Government committed $1 billion over five years to further improve Canada"s pandemic preparedness. Support of $10.8 million over three years has been allocated for the network from this 2006 funding. The Canadian Institutes of Health Research (CIHR) is the Government of Canada"s agency for health research. CIHR"s mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health-care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,000 health researchers and trainees across Canada. The Public Health Agency of Canada (PHAC) is the main Government of Canada agency responsible for public health in Canada. It was created to deliver on the Government of Canada"s commitment to help protect the health and safety of all Canadians. Its activities focus on preventing chronic diseases, like cancer and heart disease, preventing injuries and responding to public health emergencies and infectious disease outbreaks. David Coulombe Canadian Institutes of Health Research


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009